Bionano Genomics Inc (BNGO) stock news · rev $28.5M
Bionano Genomics Inc (BNGO) is a medical instruments & supplies company listed on US.
This BNGO news page leads with what Bionano Genomics Inc filed — not a scraped headline mill.
No cached 8-K sentence for BNGO yet. We will not pad this page with generic market recap.
Latest reported BNGO revenue for 2025-12-31 was $28.5M. Net income was -$26.4M. Revenue was down 7.4% from 2024-12-31 to 2025-12-31. BNGO currently screens at market cap $13.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BNGO stock page; for the tape open the quote page.
BNGO stock news FAQ
What are BNGO's latest revenue and net income?
Latest cached Bionano Genomics Inc (BNGO) revenue for Dec 31, 2025 was $28.5M. Net income was -$26.4M. Statements: https://lician.com/financials/bngo
How did BNGO revenue change from the prior cached period?
Cached Bionano Genomics Inc (BNGO) revenue was down 7.4% from $30.8M (Dec 31, 2024) to $28.5M (Dec 31, 2025). Statements: https://lician.com/financials/bngo
What is BNGO's market cap?
Bionano Genomics Inc (BNGO) market cap is $13.4M on the latest cached fundamentals snapshot.
What kind of company is BNGO?
Bionano Genomics Inc (BNGO) is a medical instruments & supplies company listed on US.
Where is BNGO stock news listed?
Cached stock news for Bionano Genomics Inc (BNGO) is listed at https://lician.com/news/bngo. Filings: https://lician.com/sec/bngo
Not investment advice.